Paradigm Asset Management’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-4,500
| Closed | -$30.6K | – | 550 |
|
|
2017
Q2 | $30.6K | Sell |
4,500
-4,600
| -51% | -$31.2K | 0.01% | 548 |
|
|
2017
Q1 | $85.9K | Buy |
+9,100
| New | +$85.9K | 0.02% | 543 |
|
|
2016
Q3 | – | Sell |
-3,000
| Closed | -$12.7K | – | 815 |
|
|
2016
Q2 | $12.7K | Hold |
3,000
| – | – | ﹤0.01% | 758 |
|
|
2016
Q1 | $13.1K | Sell |
3,000
-6,000
| -67% | -$26.2K | ﹤0.01% | 778 |
|
|
2015
Q4 | $55.2K | Buy |
+9,000
| New | +$55.2K | 0.01% | 648 |
|
|
2013
Q4 | – | Sell |
-53,500
| Closed | -$269K | – | 859 |
|
|
2013
Q3 | $269K | Buy |
+53,500
| New | +$269K | 0.04% | 445 |
|